Clinova - Product Pipeline Review - Q4 2010

Global Markets Direct, December 2010, Pages: 14

Clinova – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Clinova - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Clinova - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Clinova human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Clinova with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Clinova’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Clinova’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Clinova in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Clinova’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Clinova.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Clinova and identify potential opportunities in those areas.

List of Tables
List of Figures
Clinova Snapshot
Clinova Overview
Key Information
Key Facts
Clinova – Research and Development Overview
Key Therapeutic Areas
Clinova – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Clinova – Pipeline Products Glance
Clinova–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Clinova – Drug Profiles
CLIN 3007
Product Description
Mechanism of Action
R&D Progress
Clinova – Pipeline Analysis
Clinova – Pipeline Products by Therapeutic Class
Clinova – Company Statement
Clinova – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• The Worldwide Industry & Market Opportunities and forecasts to 2014 for Microwaves Global Military & Space-Related Systems
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans